Glaxosmithkline Pharmaceuticals (GLAXO) — Voting Results

📢 Key Event
Corrigendum issued to August 3 postal ballot notice correcting salary typo

🔄 What Changed
Corrected basic salary figure for Mr. Akshikar from Rs. 24,00,0000/- to Rs. 24,00,000/- per month

💡 Investor Takeaway
The correction does not alter the substance of the ballot matters or voting outcomes.

GlaxoSmithKline Pharmaceuticals issued a corrigendum to its August 3, 2026 postal ballot notice, correcting a typographical error in the basic salary figure for Mr. Akshikar from Rs. 24,00,0000/- to Rs. 24,00,000/- per month. The correction was communicated via email on September 1, 2026, and will be published in a newspaper notice. The revised notice, including the corrected explanatory statement, remains otherwise unchanged and is available on the company website.

📄 View Original Announcement (PDF)

📊 Stock Analysis — GLAXO ✨ Ask AI About This

About Glaxosmithkline Pharmaceuticals Ltd (GLAXO)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹50,732.03 Cr P/E: 48.3 ROE: 47.1% ROCE: 64.1% Div Yield: 1.90%

View full GLAXO stock details →

📡 Get AI alerts when GLAXO files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track GLAXO — Free

💡 Ask AI about this filing

"What is the total voting percentage achieved for each resolution?" "How does the corrected salary compare to peer CEO compensation levels?" "What is the timeline for the newspaper publication of the ballot results?"

Ask AI Free →

📊 More GLAXO filings

See all GLAXO filings →

🔥 Also filed on 1 September 2026

FORTIS Fortis Healthcare Ltd Announcement SUNPHARMA Sun Pharmaceutical Industries Ltd Announcement 544083 Shree Marutinandan Tubes Ltd Annual Report SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement JNPR Juniper Green Energy Ltd Announcement SUDARSCHEM Sudarshan Chemical Industries Ltd Announcement

View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when GLAXO files new disclosures

Track GLAXO filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track GLAXO — Free

Free account · 2 AI queries/day

About · Privacy Policy · Terms of Service · Pricing

Today's Announcements · Screener · Insights · AI Chat

Data provided by CMOTS Internet Technologies Pvt Ltd